Julien Taieb

61PUBLICATIONS
247CO-AUTHORS
Haematological tumoursMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Immunogenetics (incl. genetic immunology)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (61)

|Aug 17, 2026
Baseline circulating and tumor γδ T cells and early circulating CD8⁺PD1⁺ expansion predict response to Atezolizumab-bevacizumab in HCC.

|Jul 24, 2026
Impact on survival of severe immuno-related adverse events in deficient mismatch repair/microsatellite instable-high digestive cancers treated with immunotherapy.

|Apr 22, 2026
Postoperative Hepatic Arterial Infusion With Oxaliplatin After Surgery of Four or More Colorectal Liver Metastases: A Randomized Phase II Trial.

|Oct 30, 2025
Efficacy of immunotherapy in gastrointestinal (GI) tumors with mismatch repair deficient (MMRd) unusual phenotype: an AGEO real-world study.

Emily Alouani, Julien Taieb, David Tougeron

|Oct 29, 2025
Plasma Protein Biomarkers to Detect Early Gastric Preneoplasia and Cancer: A Prospective Study.

Quentin Giai Gianetto, Valérie Michel, Thibaut Douché

|Aug 13, 2025
FedECA: federated external control arms for causal inference with time-to-event data in distributed settings.

Jean Ogier du Terrail, Quentin Klopfenstein, Honghao Li

Pageof 11

Frequent Collaborators

14 joint publications

Thierry André

12 joint publications

David Tougeron

12 joint publications

Pierre Laurent-Puig

11 joint publications

Sara Lonardi